ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,613.22
0.64%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Destiny Pharma Plc (DEST)

  7. Destiny Pharma Plc (DEST) Noticias

DEST

Destiny Pharma (DEST)

Destiny Pharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:DEST
FechaHoraFuenteTítuloSímboloCompañía
12/06/202413:23Alliance NewsAlliance NewsEARNINGS AND TRADING: Intuitive Investments NAV rises, talks up Hui10LSE:DESTDestiny Pharma Plc
12/06/202406:16RNS Regulatory NewsDestiny Pharma PLC Result of Annual General MeetingLSE:DESTDestiny Pharma Plc
12/06/202405:00RNS Regulatory NewsDestiny Pharma PLC 2024 Annual General Meeting and StatementLSE:DESTDestiny Pharma Plc
11/06/202410:34Alliance NewsAlliance NewsEARNINGS AND TRADING: Chariot loss narrows; Destiny Pharma approvalLSE:DESTDestiny Pharma Plc
11/06/202401:00RNS Regulatory NewsDestiny Pharma PLC Destiny Pharma's XF-73 Nasal Awarded MHRA ILAPLSE:DESTDestiny Pharma Plc
24/05/202401:00RNS Regulatory NewsDestiny Pharma PLC Exercise of Options and Total Voting RightsLSE:DESTDestiny Pharma Plc
09/05/202408:35RNS Regulatory NewsDestiny Pharma PLC Posting of Annual Report and Notice of AGMLSE:DESTDestiny Pharma Plc
25/04/202414:57Alliance NewsAlliance NewsTRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading wellLSE:DESTDestiny Pharma Plc
25/04/202401:00RNS Regulatory NewsDestiny Pharma PLC Full year results and review of strategic optionsLSE:DESTDestiny Pharma Plc
08/04/202401:00RNS Regulatory NewsDestiny Pharma PLC Notice of Full Year ResultsLSE:DESTDestiny Pharma Plc
31/01/202412:28Alliance NewsAlliance NewsEARNINGS AND TRADING: STV raises holding in Two Cities TelevisionLSE:DESTDestiny Pharma Plc
31/01/202401:00RNS Regulatory NewsDestiny Pharma PLC Clinical development updateLSE:DESTDestiny Pharma Plc
22/01/202401:00UK RegulatoryDestiny Pharma PLC Appointment of Nominated Adviser and Sole BrokerLSE:DESTDestiny Pharma Plc
04/01/202408:07Alliance NewsAlliance NewsDestiny Pharma seeks to capitalise on XF-73 market potential in 2024LSE:DESTDestiny Pharma Plc
04/01/202401:00UK RegulatoryDestiny Pharma PLC Year End Business UpdateLSE:DESTDestiny Pharma Plc
20/10/202306:01Alliance NewsAlliance NewsIN THE KNOW: Destiny Pharma's XF-73 is "the real deal" amid new dataLSE:DESTDestiny Pharma Plc
20/10/202301:04UK RegulatoryDestiny Pharma PLC Grant of Share OptionsLSE:DESTDestiny Pharma Plc
19/10/202301:00UK RegulatoryDestiny Pharma PLC Director/PDMR ShareholdingLSE:DESTDestiny Pharma Plc
17/10/202305:15Alliance NewsAlliance NewsDestiny Pharma celebrates study findings on "potent" flagship drugLSE:DESTDestiny Pharma Plc
17/10/202301:01UK RegulatoryDestiny Pharma PLC XF Pipeline Update MeetingLSE:DESTDestiny Pharma Plc
17/10/202301:00UK RegulatoryDestiny Pharma PLC Publication of new microbiological data for XF-73LSE:DESTDestiny Pharma Plc
27/09/202301:00UK RegulatoryDestiny Pharma PLC Notice of XF Pipeline Update MeetingLSE:DESTDestiny Pharma Plc
20/09/202308:27Alliance NewsAlliance NewsTRADING UPDATES: Dianomi swings to loss; Epwin revenue upLSE:DESTDestiny Pharma Plc
20/09/202301:00UK RegulatoryDestiny Pharma PLC Interim ResultsLSE:DESTDestiny Pharma Plc
23/08/202301:00UK RegulatoryDestiny Pharma PLC Notice of Interim ResultsLSE:DESTDestiny Pharma Plc
31/07/202311:31Alliance NewsAlliance NewsTRADING UPDATES: MGC Pharmaceuticals granted psilocybin import permitLSE:DESTDestiny Pharma Plc
31/07/202306:01UK RegulatoryDestiny Pharma PLC Publication of new data for XF-73LSE:DESTDestiny Pharma Plc
25/07/202308:27Alliance NewsAlliance NewsIN BRIEF: Destiny Pharma says former Chair Nigel Rudd return to roleLSE:DESTDestiny Pharma Plc
25/07/202301:00UK RegulatoryDestiny Pharma PLC Appointment of new ChairmanLSE:DESTDestiny Pharma Plc
19/07/202307:16Alliance NewsAlliance NewsIN BRIEF: Destiny Pharma appoints Chris Tovey as CEO; Chair resignsLSE:DESTDestiny Pharma Plc
 Showing the most relevant articles for your search:LSE:DEST

Su Consulta Reciente

NYSE
KO
Coca Cola
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
AMEX
SPY
SPDR S&P 500
FX
EURMXN
Euro vs MXN
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados